businesspress24.com - Supreme Pharmaceuticals Announces Debt Settlement for Shares
 

Supreme Pharmaceuticals Announces Debt Settlement for Shares

ID: 1333921

(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/15 -- Supreme Pharmaceuticals Inc. (the "Company") (OTC PINK: SPRWF)(CSE: SL) advises that it has settled outstanding debts by the issuance of 500,000 shares at a deemed price of $0.3375 per share. These shares shall be subject to a 4 month trading restriction.



Contacts:
Supreme Pharmaceuticals Inc.
Investor Relations
(604) 674-2191




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Masimo to Report Fourth Quarter 2014 Financial Results After Market Close on Tuesday, February 17th
TraceLink Drives Pharma Industry Transformation, Reports 2014 Annual Revenue Growth of 137% and Two-Year Revenue CAGR of 91%
Bereitgestellt von Benutzer: Marketwired
Datum: 30.01.2015 - 15:02 Uhr
Sprache: Deutsch
News-ID 1333921
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

VANCOUVER, BRITISH COLUMBIA


Phone:

Kategorie:

Healthcare


Anmerkungen:


Diese Pressemitteilung wurde bisher 258 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Supreme Pharmaceuticals Announces Debt Settlement for Shares
"
steht unter der journalistisch-redaktionellen Verantwortung von

Supreme Pharmaceuticals Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Supreme Pharmaceuticals Inc.



 

Who is online

All members: 10 578
Register today: 4
Register yesterday: 0
Members online: 0
Guests online: 111


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.